Intermittent Versus Continuous Androgen Deprivation Therapy in Patients with Relapsing or Locally Advanced Prostate Cancer: A Phase 3b Randomised Study (ICELAND)
Authors:
Open Access
- 1 April 2016
- journal article
- research article
- Published by Elsevier in European Urology
- Vol. 69 (4) , 720-727
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Adverse Effects of Androgen Deprivation Therapy and Strategies to Mitigate ThemEuropean Urology, 2015
- Is intermittent androgen‐deprivation therapy beneficial for patients with advanced prostate cancer?BJU International, 2014
- Intermittent versus continuous androgen deprivation for locally advanced, recurrent or metastatic prostate cancer: a systematic review and meta-analysisBMC Urology, 2014
- Intermittent Androgen-deprivation Therapy in Prostate Cancer: A Critical Review Focused on Phase 3 TrialsEuropean Urology, 2013
- Treatment of Prostate Cancer With Intermittent Versus Continuous Androgen Deprivation: A Systematic Review of Randomized TrialsJournal of Clinical Oncology, 2013
- The FinnProstate Study VII: Intermittent Versus Continuous Androgen Deprivation in Patients With Advanced Prostate CancerJournal of Urology, 2012
- An international field study of the EORTC QLQ-PR25: A questionnaire for assessing the health-related quality of life of patients with prostate cancerEuropean Journal of Cancer, 2008
- Intermittent Versus Continuous Total Androgen Blockade in the Treatment of Patients with Advanced Hormone-Naive Prostate Cancer: Results of a Prospective Randomized Multicenter TrialClinical Prostate Cancer, 2002
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI: Journal of the National Cancer Institute, 1993
- Intermittent endocrine therapy for advanced prostate cancerCancer, 1986